Last chance for early bird registration for this online symposium on 18 & 19 November 2021
Register here (early bird). Deadline 15 September 2021.
The glycome has a major impact on every aspect of life sciences, from developmental biology to new forms of personalized diagnostics and therapy. After the genome and proteome, the glycome presents a new perspective on human biology and disease. This symposium gathers national and international leading scientists to provide a universal overview on current advances in the ﬁeld of glycobiology.
Our symposium takes full advantage of molecular life science developments in genetics, oncology, neurology and more. We will cover various diseases including genetics disorders, cancer, neurodevelopmental disorders, infectious diseases, as well as avenues for nutrition, health and aging. True to our Frontiers symposia, a top line-up of speakers who will provide high-quality presentations on current achievements and challenges ahead. The symposium is aimed at both junior researchers as well as faculty members.
RIMLS PhD candidates can use this symposium for their portfolio. For the RIMLS educational certificate, PhD candidates are expected to attend two New Frontiers symposia during their PhD training period.
Related news items
Large AI project receives over €95 million for ten years of public-private research23 September 2021
The Dutch Research Council (NWO) is to fund two consortia for a period of ten years. Radboudumc participates in the ROBUST consortium, which consists of 17 AI labs, eight of which are dedicated to healthcare. Radboudumc leads five of these eight labs.read more
Reading ADP-ribosylation signaling using chemical biology and interaction proteomics published in Molecular Cell22 September 2021
Kasia Kliza and Michiel Vermeulen worked on a project to synthesize biotinylated ADPr-based probes that can identify ADPr readers and determine their specificity for mono- and polyADPr. They published this in Molecular Cell.read more
Systematic analysis of short tandem repeats in 38,095 exomes provides an additional diagnostic yield22 September 2021
Christian Gilissen and colleagues published in Genetics in Medicine about their work guiding the application of short tandem repeat analysis in clinical exome sequencing.read more
New start-up Patholyt will bring AI research into pathology diagnostics21 September 2021
Patholyt is on a mission to accelerate the adoption of artificial intelligence in pathology diagnostics and improve the chances of cancer patients worldwide. Patholyt is a spin-off from Radboudumc, a frontrunner in computational pathology research.read more